{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:30Z","timestamp":1792788150098,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82574413"],"award-info":[{"award-number":["82574413"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Sanqin Scholar Innovation Team Support Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04932-y","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:24:27Z","timestamp":1786587867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A tumor microenvironment acid-responsive therapy combining fenton chemistry and chemotherapy via TNF pathway for synergistic and safe lung cancer treatment"],"prefix":"10.1186","volume":"24","author":[{"given":"Cai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0091-6695","authenticated-orcid":false,"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umid Sunnatovich","family":"Mamedov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laziz Nurkhonovich","family":"Niyazov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"4932_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"4932_CR2","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1016\/j.apsb.2024.06.010","volume":"14","author":"G Huang","year":"2024","unstructured":"Huang G, Zheng W, Zhou Y, Wan M, Hu T. Recent advances to address challenges in extracellular vesicle-based applications for lung cancer. Acta Pharm Sin B. 2024;14:3855\u201375.","journal-title":"Acta Pharm Sin B"},{"key":"4932_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","volume":"22","author":"A Lahiri","year":"2023","unstructured":"Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B, Mukherjee A, Paul MK. Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer. 2023;22:40.","journal-title":"Mol Cancer"},{"key":"4932_CR4","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1016\/j.apsb.2023.02.021","volume":"13","author":"Q Pei","year":"2023","unstructured":"Pei Q, Jiang B, Hao D, Xie Z. Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics. Acta Pharm Sin B. 2023;13:3252\u201376.","journal-title":"Acta Pharm Sin B"},{"key":"4932_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jconrel.2019.02.017","volume":"298","author":"YT Tam","year":"2019","unstructured":"Tam YT, Shin DH, Chen KE, Kwon GS. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)(8)-paclitaxel prodrug: In Vivo conversion and antitumor efficacy. J Control Release. 2019;298:186\u201393.","journal-title":"J Control Release"},{"key":"4932_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41392-025-02243-6","volume":"10","author":"Q Huang","year":"2025","unstructured":"Huang Q, Li Y, Huang Y, Wu J, Bao W, Xue C, Li X, Dong S, Dong Z, Hu S. Advances in molecular pathology and therapy of non-small cell lung cancer. Signal Transduct Target Ther. 2025;10:186.","journal-title":"Signal Transduct Target Ther"},{"key":"4932_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cis.2018.11.004","volume":"263","author":"S Ezrahi","year":"2019","unstructured":"Ezrahi S, Aserin A, Garti N. Basic principles of drug delivery systems - the case of paclitaxel. Adv Colloid Interface Sci. 2019;263:95\u2013130.","journal-title":"Adv Colloid Interface Sci"},{"key":"4932_CR8","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/s41467-020-14780-5","volume":"11","author":"S Guo","year":"2020","unstructured":"Guo S, Vieweger M, Zhang K, Yin H, Wang H, Li X, Li S, Hu S, Sparreboom A, Evers BM, Dong Y, Chiu W, Guo P. Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy. Nat Commun. 2020;11:972.","journal-title":"Nat Commun"},{"key":"4932_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1158\/1078-0432.CCR-19-2182","volume":"26","author":"DY Zhang","year":"2020","unstructured":"Zhang DY, Dmello C, Chen L, Arrieta VA, Gonzalez-Buendia E, Kane JR, Magnusson LP, Baran A, James CD, Horbinski C, Carpentier A, Desseaux C, Canney M, Muzzio M, Stupp R, Sonabend AM. Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations. Clin Cancer Res. 2020;26:477\u201386.","journal-title":"Clin Cancer Res"},{"key":"4932_CR10","doi-asserted-by":"publisher","first-page":"122537","DOI":"10.1016\/j.biomaterials.2024.122537","volume":"307","author":"S Li","year":"2024","unstructured":"Li S, Meng C, Hao Q, Zhou R, Dai L, Guo Y, Zhao S, Zhou X, Lou C, Xu J, Xu P, Yang J, Ding Y, Lv Y, Han S, Li S, Li J, Kang H, Xiao Z, Tan M, Ma X, Wu H. On\/off-switchable crosslinked PTX-nanoformulation with improved precise delivery for NSCLC brain metastases and restrained adverse reaction over nab-PTX. Biomaterials. 2024;307:122537.","journal-title":"Biomaterials"},{"key":"4932_CR11","doi-asserted-by":"publisher","first-page":"104151","DOI":"10.1016\/j.ebiom.2022.104151","volume":"82","author":"W Ceelen","year":"2022","unstructured":"Ceelen W, Sandra L, de Sande LV, Graversen M, Mortensen MB, Vermeulen A, Gasthuys E, Reynders D, Cosyns S, Hoorens A, Willaert W. Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases. EBioMedicine. 2022;82:104151.","journal-title":"EBioMedicine"},{"issue":"2023","key":"4932_CR12","first-page":"e253","volume":"4","author":"S Kumar","year":"2020","unstructured":"Kumar S, Shukla MK, Sharma AK, Jayaprakash GK, Tonk RK, Chellappan DK, Singh SK, Dua K, Ahmed F, Bhattacharyya S, Kumar D. Metal-based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy. MedComm. 2020;4(2023):e253.","journal-title":"MedComm"},{"key":"4932_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1021\/acsomega.2c04078","volume":"8","author":"A Sharma","year":"2023","unstructured":"Sharma A, Shambhwani D, Pandey S, Singh J, Lalhlenmawia H, Kumarasamy M, Singh SK, Chellappan DK, Gupta G, Prasher P, Dua K. Kumar, Advances in Lung Cancer Treatment Using Nanomedicines. ACS Omega. 2023;8:10\u201341.","journal-title":"ACS Omega"},{"key":"4932_CR14","doi-asserted-by":"publisher","first-page":"e202410649","DOI":"10.1002\/anie.202410649","volume":"63","author":"D Wang","year":"2024","unstructured":"Wang D, Yuan F, Deng X, Liu Q, Shi W, Wang X. Sub-Nanosheet Induced Inverse Growth of Negative Valency Au Clusters for Tumor Treatment by Enhanced Oxidative Stress. Angew Chem Int Ed Engl. 2024;63:e202410649.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4932_CR15","doi-asserted-by":"crossref","unstructured":"Jiang Z, Li J, Liu G, Qiu Q, Zhang J, Hao M, Ren H, Zhang Y. A pH-Sensitive Glucose Oxidase and Hemin Coordination Micelle for Multi-Enzyme Cascade and Amplified Cancer Chemodynamic Therapy, Small, (2024) e2407674.","DOI":"10.1002\/smll.202407674"},{"key":"4932_CR16","doi-asserted-by":"publisher","first-page":"7707","DOI":"10.1039\/D3CS00356F","volume":"52","author":"JN Hao","year":"2023","unstructured":"Hao JN, Ge K, Chen G, Dai B, Li Y. Strategies to engineer various nanocarrier-based hybrid catalysts for enhanced chemodynamic cancer therapy. Chem Soc Rev. 2023;52:7707\u201336.","journal-title":"Chem Soc Rev"},{"key":"4932_CR17","doi-asserted-by":"publisher","first-page":"11819","DOI":"10.1021\/acsnano.8b07635","volume":"12","author":"H Ranji-Burachaloo","year":"2018","unstructured":"Ranji-Burachaloo H, Gurr PA, Dunstan DE, Qiao GG. Cancer Treatment through Nanoparticle-Facilitated Fenton Reaction. ACS Nano. 2018;12:11819\u201337.","journal-title":"ACS Nano"},{"key":"4932_CR18","doi-asserted-by":"publisher","first-page":"e2105315","DOI":"10.1002\/advs.202105315","volume":"9","author":"S Liu","year":"2022","unstructured":"Liu S, Sun Z, Liang M, Song W, Zhang R, Shi Y, Cui Y, Gao Q. An Unrevealed Molecular Function of Corannulene Buckybowl Glycoconjugates in Selective Tumor Annihilation by Targeting the Cancer-Specific Warburg Effect. Adv Sci (Weinh). 2022;9:e2105315.","journal-title":"Adv Sci (Weinh)"},{"key":"4932_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.semcancer.2022.07.003","volume":"86","author":"G Bononi","year":"2022","unstructured":"Bononi G, Masoni S, Di Bussolo V, Tuccinardi T, Granchi C, Minutolo F. Historical perspective of tumor glycolysis: A century with Otto Warburg. Semin Cancer Biol. 2022;86:325\u201333.","journal-title":"Semin Cancer Biol"},{"key":"4932_CR20","doi-asserted-by":"publisher","first-page":"e2304058","DOI":"10.1002\/smll.202304058","volume":"19","author":"J Zhu","year":"2023","unstructured":"Zhu J, Cai H, Xu C, Wang W, Song X, Li B, Shen Y, Dong X. Acidity-Responsive Nanoreactors Destructed Warburg Effect for Toxic-Acidosis and Starvation Synergistic Therapy. Small. 2023;19:e2304058.","journal-title":"Small"},{"key":"4932_CR21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","volume":"14","author":"M Liao","year":"2024","unstructured":"Liao M, Yao D, Wu L, Luo C, Wang Z, Zhang J, Liu B. Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer. Acta Pharm Sin B. 2024;14:953\u20131008.","journal-title":"Acta Pharm Sin B"},{"key":"4932_CR22","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.7150\/thno.100036","volume":"14","author":"X Wang","year":"2024","unstructured":"Wang X, Wang L, Hao Q, Cai M, Wang X, An W. Harnessing glucose metabolism with nanomedicine for cancer treatment. Theranostics. 2024;14:6831\u201382.","journal-title":"Theranostics"},{"key":"4932_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jconrel.2023.04.046","volume":"358","author":"T Shen","year":"2023","unstructured":"Shen T, Yang S, Qu X, Chen Z, Zeng L, Sun X, Lin Y, Luo M, Lei B, Yue C, Ma C, Hu N, Wang W, Zhang L. A bionic Trojan horse-like gene delivery system hybridized with tumor and macrophage cell membrane for cancer therapy. J Control Release. 2023;358:204\u201318.","journal-title":"J Control Release"},{"key":"4932_CR24","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/anie.201805664","volume":"58","author":"Z Tang","year":"2019","unstructured":"Tang Z, Liu Y, He M, Bu W. Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reactions. Angew Chem Int Ed Engl. 2019;58:946\u201356.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4932_CR25","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/anie.201510031","volume":"55","author":"C Zhang","year":"2016","unstructured":"Zhang C, Bu W, Ni D, Zhang S, Li Q, Yao Z, Zhang J, Yao H, Wang Z, Shi J. Synthesis of Iron Nanometallic Glasses and Their Application in Cancer Therapy by a Localized Fenton Reaction. Angew Chem Int Ed Engl. 2016;55:2101\u20136.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4932_CR26","first-page":"794","volume":"51","author":"TP Szatrowski","year":"1991","unstructured":"Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991;51:794\u20138.","journal-title":"Cancer Res"},{"key":"4932_CR27","doi-asserted-by":"publisher","first-page":"e2104223","DOI":"10.1002\/adma.202104223","volume":"33","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Fan S, Feng L, Huang X, Chen X. Manipulating Intratumoral Fenton Chemistry for Enhanced Chemodynamic and Chemodynamic-Synergized Multimodal Therapy. Adv Mater. 2021;33:e2104223.","journal-title":"Adv Mater"},{"key":"4932_CR28","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41467-020-15591-4","volume":"11","author":"C Liu","year":"2020","unstructured":"Liu C, Cao Y, Cheng Y, Wang D, Xu T, Su L, Zhang X, Dong H. An open source and reduce expenditure ROS generation strategy for chemodynamic\/photodynamic synergistic therapy. Nat Commun. 2020;11:1735.","journal-title":"Nat Commun"},{"key":"4932_CR29","doi-asserted-by":"crossref","unstructured":"Jia C, Guo Y, Wu FG. Chemodynamic Therapy via Fenton and Fenton-Like Nanomaterials: Strategies and Recent Advances, Small, 18 (2022) e2103868.","DOI":"10.1002\/smll.202103868"},{"key":"4932_CR30","doi-asserted-by":"publisher","first-page":"6780","DOI":"10.1021\/acs.nanolett.0c02622","volume":"20","author":"Y Chen","year":"2020","unstructured":"Chen Y, Huang Y, Zhou S, Sun M, Chen L, Wang J, Xu M, Liu S, Liang K, Zhang Q, Jiang T, Song Q, Jiang G, Tang X, Gao X, Chen J. Tailored Chemodynamic Nanomedicine Improves Pancreatic Cancer Treatment via Controllable Damaging Neoplastic Cells and Reprogramming Tumor Microenvironment. Nano Lett. 2020;20:6780\u201390.","journal-title":"Nano Lett"},{"key":"4932_CR31","doi-asserted-by":"publisher","first-page":"39493","DOI":"10.1021\/acsami.9b13470","volume":"11","author":"L Hang","year":"2019","unstructured":"Hang L, Li H, Zhang T, Men D, Zhang C, Gao P, Zhang Q. Au@Prussian Blue Hybrid Nanomaterial Synergy with a Chemotherapeutic Drug for Tumor Diagnosis and Chemodynamic Therapy. ACS Appl Mater Interfaces. 2019;11:39493\u2013502.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4932_CR32","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1039\/C9BM01044K","volume":"7","author":"T Xue","year":"2019","unstructured":"Xue T, Xu C, Wang Y, Wang Y, Tian H, Zhang Y. Doxorubicin-loaded nanoscale metal-organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy. Biomater Sci. 2019;7:4615\u201323.","journal-title":"Biomater Sci"},{"key":"4932_CR33","doi-asserted-by":"publisher","first-page":"e1906024","DOI":"10.1002\/adma.201906024","volume":"32","author":"Z Ren","year":"2020","unstructured":"Ren Z, Sun S, Sun R, Cui G, Hong L, Rao B, Li A, Yu Z, Kan Q, Mao Z. A Metal-Polyphenol-Coordinated Nanomedicine for Synergistic Cascade Cancer Chemotherapy and Chemodynamic Therapy. Adv Mater. 2020;32:e1906024.","journal-title":"Adv Mater"},{"key":"4932_CR34","doi-asserted-by":"publisher","first-page":"36917","DOI":"10.1021\/acsami.0c09952","volume":"12","author":"R Xu","year":"2020","unstructured":"Xu R, Xu Z, Si Y, Xing X, Li Q, Xiao J, Wang B, Tian G, Zhu L, Wu Z, Zhang G. Oxygen Vacancy Defect-Induced Activity Enhancement of Gd Doping Magnetic Nanocluster for Oxygen Supplying Cancer Theranostics. ACS Appl Mater Interfaces. 2020;12:36917\u201327.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4932_CR35","doi-asserted-by":"publisher","first-page":"18156","DOI":"10.1038\/s41598-020-75372-3","volume":"10","author":"VM Lu","year":"2020","unstructured":"Lu VM, Jue TR, McDonald KL. Cytotoxic lanthanum oxide nanoparticles sensitize glioblastoma cells to radiation therapy and temozolomide: an in vitro rationale for translational studies. Sci Rep. 2020;10:18156.","journal-title":"Sci Rep"},{"key":"4932_CR36","doi-asserted-by":"publisher","first-page":"114588","DOI":"10.1016\/j.envres.2022.114588","volume":"216","author":"Z Shan","year":"2023","unstructured":"Shan Z, Ma F, You S, Shan L, Kong D, Guo H, Cui C. Enhanced visible light photo-Fenton catalysis by lanthanum-doping BiFeO(3) for norfloxacin degradation. Environ Res. 2023;216:114588.","journal-title":"Environ Res"},{"key":"4932_CR37","doi-asserted-by":"publisher","first-page":"101223","DOI":"10.1016\/j.mtbio.2024.101223","volume":"28","author":"G Zheng","year":"2024","unstructured":"Zheng G, Wu S, Deng X, Wang A, Ying Y, Li S, Wang F, Liu X, Wang P, Wei D. Lanthanum-based dendritic mesoporous nanoplatform for tumor microenvironment activating synergistic anti-glioma efficacy. Mater Today Bio. 2024;28:101223.","journal-title":"Mater Today Bio"},{"key":"4932_CR38","doi-asserted-by":"publisher","first-page":"102489","DOI":"10.1016\/j.cis.2021.102489","volume":"295","author":"H Li","year":"2021","unstructured":"Li H, Jiang B, Li J. Recent advances in dopamine-based materials constructed via one-pot co-assembly strategy. Adv Colloid Interface Sci. 2021;295:102489.","journal-title":"Adv Colloid Interface Sci"},{"key":"4932_CR39","first-page":"4426","volume":"60","author":"Y Huang","year":"2000","unstructured":"Huang Y, Johnson KR, Norris JS, Fan W. Nuclear factor-kappaB\/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells. Cancer Res. 2000;60:4426\u201332.","journal-title":"Cancer Res"},{"key":"4932_CR40","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1159\/000479439","volume":"42","author":"X Chen","year":"2017","unstructured":"Chen X, Xiu M, Xing J, Yu S, Min D, Guo F. Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-\u03baB-Jmjd3 Signaling. Cell Physiol Biochem. 2017;42:1713\u201324.","journal-title":"Cell Physiol Biochem"},{"key":"4932_CR41","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/adma.201204683","volume":"25","author":"Y Liu","year":"2013","unstructured":"Liu Y, Ai K, Liu J, Deng M, He Y, Lu L. Dopamine-melanin colloidal nanospheres: an efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy. Adv Mater. 2013;25:1353\u20139.","journal-title":"Adv Mater"},{"key":"4932_CR42","first-page":"100993","volume":"20","author":"F Wu","year":"2025","unstructured":"Wu F, An X, Li S, Qiu C, Zhu Y, Ye Z, Song S, Wang Y, Shen D, Di X, Yao Y, Zhu W, Jiang X, Shi X, Chen R, Kou L. Enhancing chemoimmunotherapy for colorectal cancer with paclitaxel and alantolactone via CD44-Targeted nanoparticles: A STAT3 signaling pathway modulation approach. Asian J Pharm Sci. 2025;20:100993.","journal-title":"Asian J Pharm Sci"},{"key":"4932_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00007691-199706000-00014","volume":"19","author":"M Andreeva","year":"1997","unstructured":"Andreeva M, Niedmann PD, Binder L, Armstrong VW, Meden H, Binder M, Oellerich M. A simple and reliable reverse-phase high-performance liquid chromatographic procedure for determination of paclitaxel (taxol) in human serum. Ther Drug Monit. 1997;19:327\u201332.","journal-title":"Ther Drug Monit"},{"key":"4932_CR44","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1049\/nbt2.12121","volume":"17","author":"A Kharazmi","year":"2023","unstructured":"Kharazmi A, Attaran N. Evaluation of the parameters affecting the loading of anticancer drug Paclitaxel on coated gold nanoparticles for breast cancer treatment. IET Nanobiotechnol. 2023;17:234\u201345.","journal-title":"IET Nanobiotechnol"},{"key":"4932_CR45","first-page":"158","volume":"41","author":"T Leng","year":"2024","unstructured":"Leng T, Zhang L, Ma J, Qu X, Lei B. Intrinsically bioactive multifunctional Poly(citrate-curcumin) for rapid lung injury and MRSA infection therapy. Bioact Mater. 2024;41:158\u201373.","journal-title":"Bioact Mater"},{"key":"4932_CR46","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12951-023-01929-9","volume":"21","author":"L Zhang","year":"2023","unstructured":"Zhang L, Niu W, Lin Y, Ma J, Leng T, Cheng W, Wang Y, Wang M, Ning J, Yang S, Lei B. Multifunctional antibacterial bioactive nanoglass hydrogel for normal and MRSA infected wound repair. J Nanobiotechnol. 2023;21:162.","journal-title":"J Nanobiotechnol"},{"key":"4932_CR47","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.ccell.2023.05.009","volume":"41","author":"C Vennin","year":"2023","unstructured":"Vennin C, Cattaneo CM, Bosch L, Vegna S, Ma X, Damstra HGJ, Martinovic M, Tsouri E, Ilic M, Azarang L, van Weering JRT, Pulver E, Zeeman AL, Schelfhorst T, Lohuis JO, Rios AC, Dekkers JF, Akkari L, Menezes R, Medema R, Baglio SR, Akhmanova A, Linn SC, Lemeer S, Pegtel DM, Voest EE, van Rheenen J. Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity. Cancer Cell. 2023;41:1170\u2013e11851112.","journal-title":"Cancer Cell"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04932-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04932-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04932-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:02:07Z","timestamp":1790110927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04932-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4932"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04932-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"891"}}